Recently, different circles have been criticizing the U.S. Food and Drug Administration regarding its poor performance to make food supply in the U.S. safe. FDA responds to this criticism in a report that details its efforts to make food supplies safe and protect consumers.

Dr. David Acheson, who is assistant commissioner for food protection at the agency, says in this connection: “The agency’s proposal to develop better relationships with different local health departments and state regarding protecting food supply was one of the most important tasks that the agency worked for.”

“And the second big success is to make the strategic change regarding imports and this act can be called FDA’s globalization, and due to this we are shifting our intentions to inspect the foods items at the time of entry. Similarly, FDA is focused to develop such systems as may help to provide better understanding of what’s happening in foreign manufacturing.”

The results of a study (included 17,800 men and women with normal levels of cholesterol) showed that rosuvastatin decreases number of deaths from heart attacks and strokes.

The results have been published in the New England Journal of Medicine.

Statins are given to people who have a moderate to high risk of a cardiovascular ‘event’.

In this trail, included people had normal cholesterol levels that were below than those levels that usually indicate a need for treatment. Those patients didn’t have any other sign of heart disease as well.

However, they had higher levels of a C-reactive protein, which indicates inflammation in the body and considered to be a maker of future cardiovascular events.

20mg of rosuvastatin seemed to cut cholesterol by 50% and C-reactive protein by 37% after an average follow-up of two years and overall, the risk for a heart attack, stroke or death from cardiovascular disease decreased by 44%.